학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 233건 | 목록
1~20
Academic Journal
Elizondo-Pacheco, L.A. ; Solari, L.A. ; He, Hai-Long ; Ramírez-Fernández, J.A. ; Maldonado, R. ; Bai, Yang
In LITHOS 1 November 2025 512-513
Academic Journal
Chen, Gregory M.; Jain, Ankita; Gering, David T.; Satulovsky, Javier; Datta, Sarbani; Lai, Peng; Karar, Jayashree; Gonzalez, Vanessa E.; Alexander, Kathleen; Chew, Anne; Jadlowsky, Julie K.; Ruella, Marco; Paruzzo, Luca; Amses, Kevin R.; Rech, Andrew J.; Stadtmauer, Edward A.; Frey, Noelle V.; Hexner, Elizabeth O.; Porter, David L.; Cohen, Adam D.; Gill, Saar I.; Garfall, Alfred L.; Schuster, Stephen J.; Mo, Kelvin C.; Liang, Samantha I.; Spasic, Marko; Levine, Bruce L.; Siegel, Don L.; Ramírez-Fernández, Angel; Cabanski, Christopher R.; Yang, EnJun; Mackall, Crystal L.; Bushman, Frederic D.; Good, Zinaida; John Wherry, E.; June, Carl H.; Fraietta, Joseph A.
Nature Biomedical Engineering. :1-12
Academic Journal
Julie K. Jadlowsky; Elizabeth O. Hexner; Amy Marshall; Stephan A. Grupp; Noelle V. Frey; James L. Riley; Elizabeth Veloso; Holly McConville; Walter Rogal; Cory Czuczman; Wei-Ting Hwang; Yimei Li; Rachel M. Leskowitz; Olivia Farrelly; Jayashree Karar; Shannon Christensen; Julie Barber-Rotenberg; Avery Gaymon; Naomi Aronson; Wendy Bernstein; Jan Joseph Melenhorst; Aoife M. Roche; John K. Everett; Sonja A. Zolnoski; Alexander G. McFarland; Shantan Reddy; Angelina Petrichenko; Emma J. Cook; Carole Lee; Vanessa E. Gonzalez; Kathleen Alexander; Irina Kulikovskaya; Ángel Ramírez-Fernández; Janna C. Minehart; Marco Ruella; Saar I. Gill; Stephen J. Schuster; Adam D. Cohen; Alfred L. Garfall; Payal D. Shah; David L. Porter; Shannon L. Maude; Bruce L. Levine; Donald L. Siegel; Anne Chew; Stephen McKenna; Lester Lledo; Megan M. Davis; Gabriela Plesa; Friederike Herbst; Edward A. Stadtmauer; Pablo Tebas; Amanda DiNofia; Andrew Haas; Naomi B. Haas; Regina Myers; Donald M. O’Rourke; Jakub Svoboda; Janos L. Tanyi; Richard Aplenc; Jeffrey M. Jacobson; Andrew H. Ko; Roger B. Cohen; Carl H. June; Frederic D. Bushman; Joseph A. Fraietta
Nature Medicine. 31:1134-1144
Academic Journal
Esther M. Cruz‐Gámez; Fernando Velasco Tapia; Augusto A. Rodríguez Díaz; Pedro Rodríguez Saavedra; Dámaso Cáceres Govea; José F. Lastra Rivero; Yolanda Pichardo Barrón; Juan A. Ramírez Fernández; Erik Castañeda Narvaez; Alexander Iriondo; Roberto O. Rábago Tavares; Agustín Rodríguez Santos
Resource Geology. 75
Academic Journal
de Oliveira, Tadeu G.; Fox-Rosales, Lester A.; Ramírez-Fernández, José D.; Cepeda-Duque, Juan C.; Zug, Rebecca; Sanchez-Lalinde, Catalina; Oliveira, Marcelo J. R.; Marinho, Paulo H. D.; Bonilla-Sánchez, Alejandra; Marques, Mara C.; Cassaro, Katia; Moreno, Ricardo; Rumiz, Damián; Peters, Felipe B.; Ortega, Josué; Cavalcanti, Gitana; Mooring, Michael S.; Blankenship, Steven R.; Brenes-Mora, Esteban; Dias, Douglas; Mazim, Fábio D.; Eizirik, Eduardo; Diehl, Jaime L.; Marques, Rosane V.; Ribeiro, Ana Carolina C.; Cruz, Reginaldo A.; Pasa, Emanuelle; Meira, Lyse P. C.; Pereira, Alex; Ferreira, Guilherme B.; de Pinho, Fernando F.; Sena, Liana M. M.; de Morais, Vinícius R.; Ribeiro Luiz, Micheli; Moura, Vitor E. C.; Favarini, Marina O.; Leal, Karla P. G.; Wagner, Paulo G. C.; dos Santos, Maurício C.; Sanderson, James; Araújo, Elienê P.; Rodrigues, Flávio H. G.
Scientific Reports. 14(1)
Academic Journal
Sandoval, Luis; Morales, Carlos O.; Ramírez-Fernández, José D.; Hanson, Paul; Murillo-Hiller, Luis Ricardo; Barrantes, Gilbert
Revista de Biología Tropical. April, 2019, Vol. 67 Issue SI, p36, 17 p.
Academic Journal
Joana Costa; Benjamín León-Macilla; Ludovika Cacopardo; Arti Ahluwalia; O. Ramírez-Fernández; Giorgio Mattei
BIOCELL
Volume 43
Issue 1
Volume 43
Issue 1
Academic Journal
Díez-Alonso L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Falgas A; Josep Carreras Leukaemia Research Institute, 08036 Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Arroyo-Ródenas J; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Romencín PA; Josep Carreras Leukaemia Research Institute, 08036 Barcelona, Spain.; Martínez A; Josep Carreras Leukaemia Research Institute, 08036 Barcelona, Spain.; Gómez-Rosel M; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Blanco B; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Jiménez-Reinoso A; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Mayado A; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), Universidad de Salamanca, 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), 37007 Salamanca, Spain.; Pérez-Pons A; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), Universidad de Salamanca, 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), 37007 Salamanca, Spain.; Aguilar-Sopeña Ó; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense, 28040 Madrid, Spain.; Lymphocyte Immunobiology Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), 28041 Madrid, Spain.; Ramírez-Fernández Á; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Segura-Tudela A; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Perez-Amill L; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, 08036 Barcelona, Spain.; Tapia-Galisteo A; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Domínguez-Alonso C; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Rubio-Pérez L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Chair for Immunology UFV/Merck, Universidad Francisco de Vitoria (UFV), Pozuelo de Alarcón, 28223 Madrid, Spain.; Jara M; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), Universidad de Salamanca, 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), 37007 Salamanca, Spain.; Solé F; Josep Carreras Leukaemia Research Institute, 08036 Barcelona, Spain.; Hangiu O; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; Almagro L; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense, 28040 Madrid, Spain.; Lymphocyte Immunobiology Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), 28041 Madrid, Spain.; Albitre Á; Centro de Biología Molecular Severo Ochoa CSIC-UAM, 28049 Madrid, Spain.; Instituto de Investigación Sanitaria La Princesa, 28006 Madrid, Spain.; Penela P; Centro de Biología Molecular Severo Ochoa CSIC-UAM, 28049 Madrid, Spain.; Instituto de Investigación Sanitaria La Princesa, 28006 Madrid, Spain.; Sanz L; Molecular Immunology Unit, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, 28222 Madrid, Spain.; Anguita E; Department of Medicine, Medical School, Universidad Complutense de Madrid, 28040 Madrid, Spain.; Department of Hematology, IML, IdISSC, Hospital Clínico San Carlos, 28040 Madrid, Spain.; Valeri A; H12O-CNIO Hematological Malignancies Clinical Research Unit, Spanish National Cancer Research (CNIO), 28029 Madrid, Spain.; Department of Hematology, Hospital Universitario 12 de Octubre-Universidad Complutense, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; García-Ortiz A; H12O-CNIO Hematological Malignancies Clinical Research Unit, Spanish National Cancer Research (CNIO), 28029 Madrid, Spain.; Department of Hematology, Hospital Universitario 12 de Octubre-Universidad Complutense, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; Río P; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Universidad Autónoma de Madrid (IIS-FJD, UAM), 28040 Madrid, Spain.; Juan M; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic de Barcelona, 08036 Barcelona, Spain.; Servei d'Immunologia, Hospital Clínic de Barcelona, 08036 Barcelona, Spain.; Plataforma Immunoterapia, Hospital Sant Joan de Deu, 08950 Barcelona, Spain.; Universitat de Barcelona, 08007 Barcelona, Spain.; Martínez-López J; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, 28029 Madrid, Spain.; H12O-CNIO Hematological Malignancies Clinical Research Unit, Spanish National Cancer Research (CNIO), 28029 Madrid, Spain.; Department of Hematology, Hospital Universitario 12 de Octubre-Universidad Complutense, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; Roda-Navarro P; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense, 28040 Madrid, Spain.; Lymphocyte Immunobiology Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), 28041 Madrid, Spain.; Martín-Antonio B; Department of Experimental Hematology, Instituto de Investigación Sanitaria Fundación Jiménez Diaz, (IIS-FJD), Universidad Autónoma de Madrid, 28040 Madrid, Spain.; Orfao A; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), Universidad de Salamanca, 37007 Salamanca, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Biomedical Research Institute of Salamanca (IBSAL), 37007 Salamanca, Spain.; Menéndez P; Josep Carreras Leukaemia Research Institute, 08036 Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Department of Biomedicine, School of Medicine, Universitat de Barcelona, 08007 Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.; Bueno C; Josep Carreras Leukaemia Research Institute, 08036 Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Álvarez-Vallina L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), 28041 Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain.; Chair for Immunology UFV/Merck, Universidad Francisco de Vitoria (UFV), Pozuelo de Alarcón, 28223 Madrid, Spain.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE
Academic Journal
Zuñiga-Aguilar E; Department of Electrical and Computational Engineer, Instituto de Ingeniería y Tecnología, Universidad Autónoma de Ciudad Juárez, Ciudad Juárez, Mexico.; Ramírez-Fernández O; Universidad Tecnologica de Mexico (UNITEC), Ciudad de México, Mexico.; Tecnológico de Monterrey, Monterrey, Mexico.; Botello-Arredondo A; Tecnológico de Monterrey, Monterrey, Mexico.
Publisher: SAGE Publications Country of Publication: United States NLM ID: 9104021 Publication Model: Print Cited Medium: Internet ISSN: 1878-3619 (Electronic) Linking ISSN: 09592989 NLM ISO Abbreviation: Biomed Mater Eng Subsets: MEDLINE
Academic Journal
Arroyo-Ródenas J; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Falgas A; Josep Carreras Leukaemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, Madrid, Spain.; Díez-Alonso L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Martinez-Moreno A; Josep Carreras Leukaemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, Madrid, Spain.; Roca-Ho H; Josep Carreras Leukaemia Research Institute, Barcelona, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, Madrid, Spain.; Gil-Etayo FJ; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Pérez-Pons A; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC; CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain.; Aguilar-Sopeña Ó; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense, Madrid, Spain.; Lymphocyte Immunobiology Group, Instituto de Investigación Sanitaria 12 de Octubre (i+12), Madrid, Spain.; Velasco-Sidro M; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Gómez-Rosel M; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Jiménez-Matías B; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Muñoz-Sánchez G; Servicio de Inmunología, Hospital Clínic de Barcelona, Barcelona, Spain.; Pacheco Y; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Bravo-Martín C; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense, Madrid, Spain.; Lymphocyte Immunobiology Group, Instituto de Investigación Sanitaria 12 de Octubre (i+12), Madrid, Spain.; Ramírez-Fernández Á; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Jiménez-Reinoso A; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; González-Navarro EA; Servicio de Inmunología, Hospital Clínic de Barcelona, Barcelona, Spain.; Juan M; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, Madrid, Spain.; Servicio de Inmunología, Hospital Clínic de Barcelona, Barcelona, Spain.; Orfao A; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service (NUCLEUS), University of Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC; CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.; Spanish Network on Mastocytosis (REMA), Toledo and Salamanca, Spain.; Blanco B; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Roda-Navarro P; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense, Madrid, Spain.; Lymphocyte Immunobiology Group, Instituto de Investigación Sanitaria 12 de Octubre (i+12), Madrid, Spain.; Bueno C; Josep Carreras Leukaemia Research Institute, Barcelona, Spain lalvarezv@ext.cnio.es cbueno@carrerasresearch.org pmenendez@carrerasresearch.org.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC; CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.; Menéndez P; Josep Carreras Leukaemia Research Institute, Barcelona, Spain lalvarezv@ext.cnio.es cbueno@carrerasresearch.org pmenendez@carrerasresearch.org.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III, Madrid, Spain.; Centro de Investigación Biomédica en Red-Oncología (CIBERONC; CB16/12/00400), Instituto de Salud Carlos III, Madrid, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Department of Biomedicine, School of Medicine, Universitat de Barcelona, Barcelona, Spain.; Institut de Recerca Hospital Sant Joan de Déu-Pediatric Cancer Center Barcelona (SJD-PCCB), Barcelona, Spain.; Álvarez-Vallina L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain lalvarezv@ext.cnio.es cbueno@carrerasresearch.org pmenendez@carrerasresearch.org.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; CNIO-HMRIB Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Hospital del Mar Research Institute Barcelona (HMRIB), Madrid/Barcelona, Spain.; Banc de Sang i Teixits (BST), Barcelona, Spain.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Journal of Biomaterials Science, Polymer Edition. 25:729-747
Academic Journal
Rubio-Pérez L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Chair for Immunology UFV/Merck, Universidad Francisco de Vitoria (UFV), Madrid, Spain.; Lázaro-Gorines R; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Harwood SL; Department of Molecular Biology and Genetics, Aarhus University, Aarhus C, Denmark.; Compte M; Department of Antibody Engineering, Leadartis SL, QUBE Technology Park, Madrid, Spain.; Navarro R; Department of Antibody Engineering, Leadartis SL, QUBE Technology Park, Madrid, Spain.; Tapia-Galisteo A; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Bonet J; Institute of Bioengineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; Blanco B; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Lykkemark S; Immunotherapy and Cell Engineering Laboratory, Department of Engineering, Aarhus University, Aarhus C, Denmark.; Ramírez-Fernández Á; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Ferreras-Gutiérrez M; Centro de Investigaciones Biológicas Margarita Salas (CIB), CSIC, Madrid, Spain.; Domínguez-Alonso C; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Díez-Alonso L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Segura-Tudela A; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Hangiu O; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Department of Antibody Engineering, Leadartis SL, QUBE Technology Park, Madrid, Spain.; Erce-Llamazares A; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Department of Antibody Engineering, Leadartis SL, QUBE Technology Park, Madrid, Spain.; Blanco FJ; Centro de Investigaciones Biológicas Margarita Salas (CIB), CSIC, Madrid, Spain.; Santos C; Faculty of Experimental Sciences, Universidad Francisco de Vitoria (UFV), Madrid, Spain.; Rodríguez-Peralto JL; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Pathology, Universidad Complutense, Madrid, Spain.; Cutaneous Oncology Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Centro de Investigación Biomédica en Red en Oncología (CIBERONC), Madrid, Spain.; Sanz L; Centro de Investigación Biomédica en Red en Oncología (CIBERONC), Madrid, Spain.; Molecular Immunology Unit, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.; Álvarez-Vallina L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Chair for Immunology UFV/Merck, Universidad Francisco de Vitoria (UFV), Madrid, Spain.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Academic Journal
In: OBM Transplantation . (OBM Transplantation, 2025, 9(1))
Academic Journal
International Journal of Medical Engineering and Informatics. 14:306
Academic Journal
Gómez Guillén, M.; Galbis Pérez, Juan Antonio; Areces Bravo, P.; Fernández García-Hierro, J. L.; Ávalos González, M.; Ramírez Fernández, J. M.
idUS. Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)
instname
Universidad de Sevilla (US)
instname
Academic Journal
Ramírez-Fernández Á; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital, Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Aguilar-Sopeña Ó; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense, Madrid, Spain.; Lymphocyte Immunobiology Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Díez-Alonso L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital, Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Segura-Tudela A; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital, Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Domínguez-Alonso C; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital, Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Roda-Navarro P; Department of Immunology, Ophthalmology and ENT, School of Medicine, Universidad Complutense, Madrid, Spain.; Lymphocyte Immunobiology Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Álvarez-Vallina L; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital, Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (RICORS, RD21/0017/0029), Madrid, Spain.; Blanco B; Cancer Immunotherapy Unit (UNICA), Department of Immunology, Hospital, Universitario 12 de Octubre, Madrid, Spain.; Immuno-Oncology and Immunotherapy Group, Instituto de Investigación Sanitaria 12 de Octubre (imas12), Madrid, Spain.; Red Española de Terapias Avanzadas (TERAV), Instituto de Salud Carlos III (RICORS, RD21/0017/0029), Madrid, Spain.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Book
O. Ramírez-Fernández; R. Godínez; J. Morales; L. E. Gómez-Quiroz; M. C. Gutiérrez-Ruiz; E. Zúñiga-Aguilar; R. Olayo
IFMBE Proceedings ISBN: 9783319131160
Book
O. Ramírez-Fernández; R. Godínez; J. Morales; L. E. Gómez-Quiroz; M. C. Gutiérrez-Ruiz; E. Zúñiga-Aguilar; R. Olayo
IFMBE Proceedings ISBN: 9783642211973
Book
E. Zuñiga-Aguilar; R. Godínez; MA. Morales; F. Cifuentes; O. Ramírez-Fernández; J. Morales; R. Olayo
IFMBE Proceedings ISBN: 9783642211973
Academic Journal
Universidad Autónoma Metropolitana
UAM
Redalyc-UAM
Revista Mexicana de Ingeniería Biomédica (México) Num.3 Vol.37
UAM
Redalyc-UAM
Revista Mexicana de Ingeniería Biomédica (México) Num.3 Vol.37
검색 결과 제한하기
제한된 항목
[검색어] Ramírez-Fernández, O.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어